0.00Open0.90Pre Close0 Volume11 Open Interest2.50Strike Price0.00Turnover245.84%IV0.62%PremiumAug 16, 2024Expiry Date0.89Intrinsic Value100Multiplier11DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.7804Delta0.4205Gamma1.95Leverage Ratio-0.0088Theta-0.0006Rho-1.52Eff Leverage0.0009Vega
Standard BioTools Stock Discussion
assay services, kits and related revenue in 2024; and
-- Ended the quarter with cash, cash equivalents, restricted cash and
short-term investments of $464 million, after accounting for $71 million
cash payments for merger-related expenses, settlement of year-end
operating accruals, debt retirement and completed stock buybacks.
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
Benzinga· 1 min ago
No comment yet